Tag Archives: Jesper Sig Mathiasen

Chr. Hansen’s MyOli™ 6’-SL HMO Receives EU Approval for Infant Formula and Follow-On Formula

(IN BRIEF) Chr. Hansen has received approval from the EU for their 6’-SL HMO, the final addition to their MyOli™ 5 HMO Mix. This authorization allows the highest use level of 6’-SL in infant formula and follow-on formula in the … Read the full press release

More markets around the world approve the Chr. Hansen’s Human Milk Oligosaccharides for infant formula

(PRESS RELEASE) HOERSHOLM, Denmark, 12-Sep-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH: CHR), a Danish bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries, has announced new regulatory approvals around the world for … Read the full press release

Mehr Märkte auf der ganzen Welt genehmigen die Chr. Hansen’s Human Milk Oligosaccharides für Säuglingsnahrung

(PRESSEMITTEILUNG) HOERSHOLM, Denmark, 12-Sep-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH: CHR), ein Däne Biowissenschaftsunternehmen, das Lösungen für natürliche Inhaltsstoffe für die Lebensmittel-, Ernährungs-, Pharma- und Landwirtschaftsindustrie entwickelt, hat weltweit neue behördliche Zulassungen für seine Humanmilch-Oligosaccharide für Säuglingsanfangsnahrung bekannt … Read the full press release

Chr. L’étude Hansen, le plus grand ensemble de données à ce jour, sur les oligosaccharides du lait humain (HMO) confirme la sécurité de l’apport même à des concentrations élevées

(COMMUNIQUÉ DE PRESSE) HOERSHOLM, Denmark, 11-Apr-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH : CHR), une société danoise de biosciences qui développe des solutions d’ingrédients naturels pour les industries alimentaires, nutritionnelles, pharmaceutiques et agricoles, a annoncé la sortie de son … Read the full press release

Chr. Hansen study, the largest data set to date, on the Human Milk Oligosaccharides (HMOs) confirms the safety of intake even at high concentrations

(PRESS RELEASE) HOERSHOLM, Denmark, 11-Apr-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH: CHR), a Danish bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries, has announced the release of its study, published in … Read the full press release